Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

goserelin acetate

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Generic mfg.

Drug class:

GnRH agonist

Related drugs:

‹

leuprolide acetate (14)

triptorelin (9)

histrelin acetate (5)

leuprolide 6-month depot (1)

leuprorelin depot (1)

leuprolide acetate for depot suspension (1)

buserelin acetate (0)

leuprolide acetate (14)

triptorelin (9)

histrelin acetate (5)

leuprolide 6-month depot (1)

leuprorelin depot (1)

leuprolide acetate for depot suspension (1)

buserelin acetate (0)

›

No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	goserelin acetate + flutamide Sensitive: A1 - Approval goserelin acetate + flutamide Sensitive : A1	goserelin acetate + flutamide Sensitive: A1 - Approval goserelin acetate + flutamide Sensitive : A1
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	goserelin acetate Sensitive: A1 - Approval goserelin acetate Sensitive : A1	goserelin acetate Sensitive: A1 - Approval goserelin acetate Sensitive : A1
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	goserelin acetate Sensitive: A1 - Approval goserelin acetate Sensitive : A1	goserelin acetate Sensitive: A1 - Approval goserelin acetate Sensitive : A1
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	bicalutamide + goserelin acetate Sensitive: A2 - Guideline bicalutamide + goserelin acetate Sensitive : A2	bicalutamide + goserelin acetate Sensitive: A2 - Guideline bicalutamide + goserelin acetate Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	goserelin acetate + nilutamide Sensitive: A2 - Guideline goserelin acetate + nilutamide Sensitive : A2	goserelin acetate + nilutamide Sensitive: A2 - Guideline goserelin acetate + nilutamide Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	abiraterone acetate + goserelin acetate Sensitive: A2 - Guideline abiraterone acetate + goserelin acetate Sensitive : A2	abiraterone acetate + goserelin acetate Sensitive: A2 - Guideline abiraterone acetate + goserelin acetate Sensitive : A2
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	tamoxifen + goserelin acetate Sensitive: C2 – Inclusion Criteria tamoxifen + goserelin acetate Sensitive : C2	tamoxifen + goserelin acetate Sensitive: C2 – Inclusion Criteria tamoxifen + goserelin acetate Sensitive : C2